Relay Therapeutics, Inc. (RLAY)

Relay Therapeutics Statistics

Total Valuation

RLAY has a market cap or net worth of $456.01 million. The enterprise value is -$276.81 million.

Market Cap	456.01M
Enterprise Value	-276.81M

Important Dates

The next estimated earnings date is Thursday, May 1, 2025, after market close.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

RLAY has 169.52 million shares outstanding. The number of shares has increased by 16.55% in one year.

Current Share Class	169.52M
Shares Outstanding	169.52M
Shares Change (YoY)	+16.55%
Shares Change (QoQ)	+19.33%
Owned by Insiders (%)	1.92%
Owned by Institutions (%)	71.48%
Float	119.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	38.40
Forward PS	87.78
PB Ratio	0.58
P/TBV Ratio	0.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.95, with a Debt / Equity ratio of 0.06.

Current Ratio	15.95
Quick Ratio	15.40
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -44.15% and return on invested capital (ROIC) is -29.54%.

Return on Equity (ROE)	-44.15%
Return on Assets (ROA)	-28.11%
Return on Invested Capital (ROIC)	-29.54%
Return on Capital Employed (ROCE)	-47.00%
Revenue Per Employee	$38,341
Profits Per Employee	-$1.29M
Employee Count	261
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.01% in the last 52 weeks. The beta is 1.70, so RLAY's price volatility has been higher than the market average.

Beta (5Y)	1.70
52-Week Price Change	-60.01%
50-Day Moving Average	3.22
200-Day Moving Average	5.43
Relative Strength Index (RSI)	48.08
Average Volume (20 Days)	2,989,002

Short Selling Information

The latest short interest is 18.06 million, so 10.65% of the outstanding shares have been sold short.

Short Interest	18.06M
Short Previous Month	19.12M
Short % of Shares Out	10.65%
Short % of Float	15.09%
Short Ratio (days to cover)	6.63

Income Statement

In the last 12 months, RLAY had revenue of $10.01 million and -$337.71 million in losses. Loss per share was -$2.36.

Revenue	10.01M
Gross Profit	-305.43M
Operating Income	-385.67M
Pretax Income	-322.83M
Net Income	-337.71M
EBITDA	-380.21M
EBIT	-385.67M
Loss Per Share	-$2.36

Balance Sheet

The company has $781.32 million in cash and $48.50 million in debt, giving a net cash position of $732.82 million or $4.32 per share.

Cash & Cash Equivalents	781.32M
Total Debt	48.50M
Net Cash	732.82M
Net Cash Per Share	$4.32
Equity (Book Value)	777.79M
Book Value Per Share	4.64
Working Capital	758.48M

Cash Flow

In the last 12 months, operating cash flow was -$249.11 million and capital expenditures -$2.02 million, giving a free cash flow of -$251.13 million.

Operating Cash Flow	-249.11M
Capital Expenditures	-2.02M
Free Cash Flow	-251.13M
FCF Per Share	-$1.48

Margins

Gross Margin	n/a
Operating Margin	-3,854.04%
Pretax Margin	-3,374.72%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RLAY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.55%
Shareholder Yield	n/a
Earnings Yield	-74.06%
FCF Yield	-55.07%

Analyst Forecast

The average price target for RLAY is $19.33, which is 617.25% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.33
Price Target Difference	617.25%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	101.55%
EPS Growth Forecast (5Y)	-46.67%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RLAY has an Altman Z-Score of 3.36 and a Piotroski F-Score of 1.

Altman Z-Score	3.36
Piotroski F-Score	1